Bengaluru: Biotech major Biocon on Thursday said its Malaysian subsidiary has won a Rs 460 crore order to supply recombinant human insulin to the Malaysian health ministry.

"The insulin cartridges and re-usable pens will be produced and supplied from our biopharmaceutical plant at Johor in Malyasia under its government's off-take agreement initiative, which promotes local manufacturing and lowers reliance on imported medicines," the city-based pharma said in a statement here.